Zimmer Biomet Holdings, Inc. (ZBH) Return on Equity (ROE): 6.01%
Is Zimmer Biomet Holdings, Inc.’s return on equity (ROE) high or low?
Zimmer Biomet Holdings, Inc.'s return on equity (ROE) of 6.01% is 44% above its 5-year average of 4.16%, near the high end of its 5-year range (-1.14%–8.20%).
As of Saturday, June 20, 2026. 6.09% below its 12-month average of 6.40%.
ZBH Return on Equity (ROE) Chart
ZBH Average Return on Equity (ROE) Chart
ZBH Current vs Average Return on Equity (ROE) Chart
ZBH Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
6.01%
RETURN ON EQUITY (ROE) AVG TTM
6.40%
RETURN ON EQUITY (ROE) AVG 3Y
5.73%
RETURN ON EQUITY (ROE) AVG 5Y
4.16%
RETURN ON EQUITY (ROE) AVG 10Y
4.62%
RETURN ON EQUITY (ROE) AVG 15Y
6.93%
RETURN ON EQUITY (ROE) AVG 20Y
8.83%
CURRENT VS TTM AVG
-6.09%
CURRENT VS 3Y AVG
+4.84%
CURRENT VS 5Y AVG
+44.47%
CURRENT VS 10Y AVG
+30.04%
CURRENT VS 15Y AVG
-13.33%
CURRENT VS 20Y AVG
-31.95%
ZBH Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $17.02B | 6.01% | 6.40% | 5.73% | 4.16% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 10.37% | 13.30% | 15.60% | 24.66% |
| DaVita Inc. (DVA)vs › | $13.34B | -114.70% | 329.18% | 200.63% | 164.66% |
| Medpace Holdings, Inc. (MEDP)vs › | $13.14B | 76.95% | 73.63% | 65.34% | 49.74% |
| Solventum Corporation (SOLV)vs › | $13.06B | 28.82% | 23.51% | 17.50% | 13.68% |
| Labcorp Holdings Inc. (LH)vs › | $20.98B | 10.79% | 9.71% | 9.35% | 12.84% |
| Align Technology, Inc. (ALGN)vs › | $13.04B | 10.36% | 10.54% | 10.84% | 19.93% |
| The Cooper Companies, Inc. (COO)vs › | $12.85B | 2.86% | 4.70% | 4.67% | 11.22% |
| United Therapeutics Corporation (UTHR)vs › | $22.78B | 21.82% | 18.68% | 17.25% | 16.03% |
| Revvity, Inc. (RVTY)vs › | $11.16B | 3.35% | 3.59% | 3.35% | 7.68% |
Return Analysis
ROE
6.0%
ROA
3.4%
Zimmer Biomet Holdings, Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Zimmer Biomet Holdings, Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The return on equity (ROE) for ZBH stock is 6.01%.
- Is Zimmer Biomet Holdings, Inc.'s return on equity (ROE) high or low?
- Zimmer Biomet Holdings, Inc.'s return on equity (ROE) of 6.01% is 44% above its 5-year average of 4.16%, near the high end of its 5-year range (-1.14%–8.20%).
- What is the TTM average return on equity (ROE) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The TTM average return on equity (ROE) for ZBH stock is 6.40%.
- What is the 3Y average return on equity (ROE) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 3Y average return on equity (ROE) for ZBH stock is 5.73%.
- What is the 5Y average return on equity (ROE) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 5Y average return on equity (ROE) for ZBH stock is 4.16%.
- What is the 10Y average return on equity (ROE) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 10Y average return on equity (ROE) for ZBH stock is 4.62%.
- What is the 15Y average return on equity (ROE) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 15Y average return on equity (ROE) for ZBH stock is 6.93%.
- What is the 20Y average return on equity (ROE) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The 20Y average return on equity (ROE) for ZBH stock is 8.83%.
Zimmer Biomet Holdings, Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 5.55% |
| 2024-12-31 | 7.25% |
| 2023-12-31 | 8.20% |
| 2022-12-31 | 1.93% |
| 2021-12-31 | 3.17% |
| 2020-12-31 | -1.14% |
| 2019-12-31 | 9.13% |
| 2018-12-31 | -3.36% |
| 2017-12-31 | 15.46% |
| 2016-12-31 | 3.16% |
| 2015-12-31 | 1.49% |
| 2014-12-31 | 11.00% |
| 2013-12-31 | 12.08% |
| 2012-12-31 | 12.88% |
| 2011-12-31 | 13.81% |
| 2010-12-31 | 10.34% |
| 2009-12-31 | 12.72% |
| 2008-12-31 | 15.02% |
| 2007-12-31 | 14.19% |
| 2006-12-31 | 16.96% |
| 2005-12-31 | 15.64% |
| 2004-12-31 | 13.74% |
| 2003-12-31 | 11.02% |
| 2002-12-31 | 70.38% |
| 2001-12-31 | 190.34% |
| 2000-12-31 | 67.43% |
| 1999-12-31 | 38.36% |
| 1998-12-31 | 0.00% |
Related Metrics
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos